Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asymptomatic Infections | 1 | 2021 | 34 | 0.810 |
Why?
|
Nephrotic Syndrome | 1 | 2021 | 57 | 0.800 |
Why?
|
Patient Care Management | 1 | 2021 | 94 | 0.770 |
Why?
|
Ureteral Obstruction | 1 | 2018 | 143 | 0.580 |
Why?
|
Uganda | 5 | 2020 | 74 | 0.570 |
Why?
|
Peritoneal Dialysis | 1 | 2018 | 125 | 0.570 |
Why?
|
Ureter | 1 | 2018 | 209 | 0.550 |
Why?
|
Catheters, Indwelling | 1 | 2018 | 374 | 0.530 |
Why?
|
Remission Induction | 1 | 2021 | 3569 | 0.520 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 787 | 0.510 |
Why?
|
Allied Health Personnel | 1 | 2015 | 73 | 0.500 |
Why?
|
Infection Control | 1 | 2015 | 270 | 0.460 |
Why?
|
Kidney Transplantation | 1 | 2018 | 755 | 0.410 |
Why?
|
Malaria, Cerebral | 1 | 2011 | 4 | 0.400 |
Why?
|
Parasitemia | 1 | 2011 | 23 | 0.400 |
Why?
|
Kidney Failure, Chronic | 1 | 2018 | 960 | 0.370 |
Why?
|
Kidney | 1 | 2018 | 2146 | 0.340 |
Why?
|
Quality Improvement | 1 | 2015 | 851 | 0.320 |
Why?
|
Proteinuria | 2 | 2021 | 155 | 0.300 |
Why?
|
HIV Infections | 3 | 2018 | 2134 | 0.270 |
Why?
|
HIV-1 | 1 | 2011 | 653 | 0.270 |
Why?
|
Acute Kidney Injury | 1 | 2013 | 739 | 0.270 |
Why?
|
Anemia | 2 | 2020 | 689 | 0.190 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2020 | 81 | 0.180 |
Why?
|
Edema | 1 | 2021 | 267 | 0.180 |
Why?
|
Capacity Building | 2 | 2018 | 30 | 0.180 |
Why?
|
Child, Preschool | 4 | 2021 | 16273 | 0.170 |
Why?
|
Vitamin D Deficiency | 1 | 2020 | 115 | 0.170 |
Why?
|
Hypercholesterolemia | 1 | 2021 | 259 | 0.170 |
Why?
|
Urogenital Abnormalities | 1 | 2020 | 174 | 0.160 |
Why?
|
Urologic Surgical Procedures | 1 | 2018 | 93 | 0.150 |
Why?
|
Transplants | 1 | 2018 | 52 | 0.150 |
Why?
|
Foreign-Body Migration | 1 | 2018 | 117 | 0.150 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 310 | 0.150 |
Why?
|
Infant | 4 | 2018 | 13310 | 0.140 |
Why?
|
Atypical Hemolytic Uremic Syndrome | 1 | 2015 | 19 | 0.140 |
Why?
|
Education, Nursing | 1 | 2015 | 18 | 0.130 |
Why?
|
Child | 5 | 2022 | 29154 | 0.130 |
Why?
|
Midwifery | 1 | 2015 | 38 | 0.130 |
Why?
|
Catheter-Related Infections | 1 | 2018 | 270 | 0.130 |
Why?
|
Medical History Taking | 1 | 2015 | 173 | 0.130 |
Why?
|
Education, Medical | 1 | 2018 | 331 | 0.120 |
Why?
|
Physical Examination | 1 | 2015 | 299 | 0.120 |
Why?
|
Female | 8 | 2021 | 141928 | 0.110 |
Why?
|
Infant, Newborn | 2 | 2018 | 8223 | 0.110 |
Why?
|
Thinness | 1 | 2013 | 82 | 0.110 |
Why?
|
Kidney Function Tests | 1 | 2013 | 192 | 0.110 |
Why?
|
Malaria | 1 | 2013 | 92 | 0.110 |
Why?
|
Health Personnel | 1 | 2018 | 625 | 0.110 |
Why?
|
Disease Management | 1 | 2018 | 1052 | 0.110 |
Why?
|
Robotic Surgical Procedures | 1 | 2018 | 481 | 0.100 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 945 | 0.100 |
Why?
|
Creatinine | 1 | 2013 | 531 | 0.100 |
Why?
|
Antimalarials | 1 | 2011 | 55 | 0.100 |
Why?
|
Gastroenteritis | 1 | 2013 | 300 | 0.090 |
Why?
|
Humans | 10 | 2022 | 261506 | 0.090 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 4314 | 0.090 |
Why?
|
Patient Education as Topic | 1 | 2015 | 748 | 0.090 |
Why?
|
CD4 Lymphocyte Count | 1 | 2011 | 297 | 0.090 |
Why?
|
HIV Seropositivity | 1 | 2011 | 144 | 0.090 |
Why?
|
Risk | 1 | 2013 | 1972 | 0.080 |
Why?
|
Treatment Outcome | 2 | 2021 | 32848 | 0.080 |
Why?
|
Odds Ratio | 1 | 2013 | 2316 | 0.080 |
Why?
|
Renal Dialysis | 1 | 2015 | 945 | 0.080 |
Why?
|
Disease Susceptibility | 1 | 2011 | 538 | 0.080 |
Why?
|
Sex Factors | 1 | 2013 | 2139 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2013 | 1274 | 0.080 |
Why?
|
Clinical Competence | 1 | 2015 | 1270 | 0.080 |
Why?
|
Male | 5 | 2020 | 123000 | 0.070 |
Why?
|
Pneumonia | 1 | 2013 | 751 | 0.070 |
Why?
|
Quality of Life | 1 | 2020 | 4532 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 2011 | 698 | 0.070 |
Why?
|
Logistic Models | 1 | 2013 | 3441 | 0.070 |
Why?
|
Prevalence | 1 | 2013 | 3260 | 0.070 |
Why?
|
Adolescent | 2 | 2018 | 31252 | 0.060 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2015 | 3251 | 0.060 |
Why?
|
Age Factors | 1 | 2013 | 5377 | 0.060 |
Why?
|
Minerals | 1 | 2022 | 71 | 0.050 |
Why?
|
Ferric Compounds | 1 | 2022 | 73 | 0.050 |
Why?
|
Phosphates | 1 | 2022 | 187 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2011 | 6100 | 0.050 |
Why?
|
Fibroblast Growth Factors | 1 | 2022 | 257 | 0.050 |
Why?
|
Iron | 1 | 2022 | 376 | 0.040 |
Why?
|
Random Allocation | 1 | 2018 | 703 | 0.040 |
Why?
|
Health Services Research | 1 | 2018 | 233 | 0.040 |
Why?
|
Retrospective Studies | 1 | 2018 | 37905 | 0.030 |
Why?
|
Adult | 2 | 2018 | 77950 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 2594 | 0.030 |
Why?
|
Risk Factors | 1 | 2011 | 17523 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 3472 | 0.020 |
Why?
|
Young Adult | 1 | 2018 | 21445 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 29902 | 0.010 |
Why?
|
Aged | 1 | 2018 | 70117 | 0.010 |
Why?
|
Middle Aged | 1 | 2018 | 86204 | 0.010 |
Why?
|